In response to the Letter to the Editor by Romach et al. re our publication “Dolutegravir in pregnant mice is associated with increased rates of fetal defects at therapeutic but not at supratherapeutic levels”

Detalles Bibliográficos
Autores principales: Mohan, H., Guzman Lenis, M., Laurette, E.Y., Tejada, O., Sanghvi, T., Leung, K.-Y., Cahill, L.S., Sled, J.G., Delgado-Olguín, P., Greene, N.D.E., Copp, A.J., Serghides, L.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Letter
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054139/
https://www.ncbi.nlm.nih.gov/pubmed/33862586
http://dx.doi.org/10.1016/j.ebiom.2021.103334

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8054139/
https://www.ncbi.nlm.nih.gov/pubmed/33862586
http://dx.doi.org/10.1016/j.ebiom.2021.103334

Ejemplares similares